尽管报告Q4收入和收入增长强劲,但辉瑞的股票却跌到了12个月的最低点。
Pfizer's stock hits a 12-month low despite reporting strong Q4 earnings and revenue growth.
尽管Q4收入和收入增长强劲,但Pfizer Inc.看到其股票跌入新的12个月最低点。
Pfizer Inc. saw its stock hit a new 12-month low despite strong Q4 earnings and revenue growth.
该公司报告说,收入增加了24.7%,达到177.6亿美元,每股0.63美元,比预期的收入少6.3美元。
The company reported a 24.7% increase in revenue to $17.76 billion and beat earnings expectations with $0.63 per share.
一些机构投资者减少了股份,而另一些机构投资者增加了股份。
Several institutional investors reduced their stakes, while others increased holdings.
Pfizer有一个“机动买家”的共识评级,目标价格为31.92美元。
Pfizer has a "Moderate Buy" consensus rating with a target price of $31.92.
尽管最近股票下跌,分析师仍然对该公司的未来业绩持乐观态度。
Despite the recent stock dip, analysts remain optimistic about the company's future performance.